JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Infographic
How LentiBOOST technology addresses 5 top cell therapy development challenges
Struggling to navigate cell therapy development hurdles? Discover how LentiBOOST™ transduction enhancer helps overcome 5 critical challenges facing cell therapy developers.
Already used in 2 approved therapies and 40+ clinical trials, this clinic-ready technology can turn development obstacles into competitive advantages.
- Reaching the next milestone
- High manufacturing costs
- Scalability issues
- Clinical response rate
- Regulatory risk
Download the infographic to see how LentiBOOST technology can help to unlock your cell therapy program's potential.
LentiBOOST Pharma-Grade technology: For research use only. Not for use in diagnostic procedures.
LentiBOOST GMP Grade technology: Not for diagnostic use. Other applications must be authorized by a license from Revvity.
Download Resource
How LentiBOOST technology addresses 5 top cell therapy development challenges